Cobra Biologics Limited
Cobra Biologics Limited, a leading contract development and manufacturing organisation (CDMO), is headquartered in the United Kingdom. Established in 2003, Cobra has made significant strides in the biopharmaceutical industry, specialising in the production of plasmid DNA, viral vectors, and cell line development. With operational facilities in both the UK and Sweden, the company serves a global clientele, providing tailored solutions for gene therapy and vaccine development.
Cobra's core offerings include high-quality plasmid DNA and viral vector production, distinguished by their commitment to stringent quality standards and regulatory compliance. The company has achieved notable milestones, including successful collaborations with prominent biotech firms, solidifying its position as a trusted partner in the biomanufacturing landscape. With a focus on innovation and customer-centric services, Cobra Biologics continues to play a pivotal role in advancing biopharmaceutical development.
+31 vs industry average
Cobra Biologics Limited’s score of 69 is higher than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Cobra Biologics Limited?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Cobra Biologics Limited yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Cobra Biologics Limited’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Cobra Biologics Limited yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Charles River Laboratories International, Inc.
Carbon Disclosure Project
Inherited from Charles River Laboratories International, Inc.The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Inherited from Charles River Laboratories International, Inc.Climate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project